NCT02484833
- Conditions
- Antineoplastic Agents, Colonic Diseases, Colorectal Neoplasms, +9 more
- Locations
-
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy
Clinical trial condition
Antineoplastic Agents
Explore clinical trials studying Antineoplastic Agents. Study availability and eligibility vary by location and protocol.
18 public trials
6 recruiting studies
Antineoplastic Agents trial results
NCT03403777
- Conditions
- Antineoplastic Agents, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- National Cancer Institute Bratislava, Slovakia
NCT01316458
- Conditions
- Abdominal Neoplasms, Antineoplastic Agents, Female Urogenital Diseases, +14 more
- Locations
-
- Novartis Investigative Site Aachen, Germany
- Novarts Investigative Site Berlin, Germany
- Novartis Investigative Site Bonn, Germany
- Novartis Investigative Site Borken, Germany
Completed
Tablet-based Patient Reported Outcome
NCT01991691
- Conditions
- Antineoplastic Agents
- Locations
-
- Department of Obstetrics & Gynecology, Evangelisches Krankenhaus Bergisch-Gladbach Bergisch Gladbach, Germany
- Department of Obstetrics & Gynecology, University Hospital Bonn Bonn, Germany
- Department of Obstetrics & Gynecology, University Hospital Cologne Cologne, Germany
Completed
Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography
NCT00541801
- Conditions
- Antineoplastic Agents, Cardiovascular Diseases, Heart Diseases, +2 more
- Locations
-
- Kantonsspital Luzern, Department of Cardiology Lucerne, Canton of Lucerne, Switzerland
Completed
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
NCT01169792
- Conditions
- Antineoplastic Agents, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine Jin-Gu, Busan, South Korea
- Department of Surgery, Yonsei University College of Medicine Saedaemoon-gu, Seoul, South Korea
NCT05288166
- Conditions
- Abiraterone Acetate, Androgens, Antineoplastic Agents, +27 more
- Locations
-
- Arizona Oncology Associates, P.C. - HOPE Prescott, Arizona, United States
- Arizona Oncology Associates, P.C. - HOPE Prescott Valley, Arizona, United States
- The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
- Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
Active, Not Recruiting
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
NCT04807166
- Conditions
- Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
- Locations
-
- Huai'an First People's Hospital Huai'an, China
- Nanjing Drum Tower Hospital Nanjing, China
- Zhongda Hospital Southeast University Nanjing, China
- The First Affiliated Hospital of Soochow University Suzhou, China